AI assistant
Sending…
RESMED INC — Director's Dealing 2020
Oct 6, 2020
30071_dirs_2020-10-06_6e7b2a70-2760-4f55-a174-989baaeba241.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-08-20
Reporting Person: Leong Justin (President, Asia Latin America)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ReMed Common Stock | 25386 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| ResMed Common Stock Options | $190.86 | 2027-07-01 | ResMed Common Stock (4187) | Direct | |
| ResMed Common Stock Options | $57.76 | 2023-11-16 | ResMed Common Stock (22740) | Direct |
Footnotes
F1: Represents date options first became exercisable. Options vest 1/3 per year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29